| Serial Number | 90191359 |
| Word Mark | BROMAC |
| Filing Date | Friday, September 18, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 18, 2022 |
| Registration Number | 6617801 |
| Registration Date | Tuesday, January 18, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 2, 2021 |
| Goods and Services | Anti-bacterial pharmaceuticals; anti-cancer drugs; anti-cancer pharmaceutical preparations; anti-fungal preparations; antiviral pharmaceutical preparations; bacteria removers, namely, antimicrobial preparations for inhibiting the growth of bacteria; biofilm removers, namely, antimicrobial preparations for inhibiting the growth of biofilms; biological preparations for the treatment of cancer and pseudomyxoma peritonei; chemical preparations containing enzymes for pharmaceutical purposes, namely, for the prevention and treatment of cancer and pseudomyxoma peritonei, for inhibiting the growth of bacteria or biofilms, for destroying biofilm infections, or for treating cystic fibrosis, sputum retention, chest infections, respiratory conditions, severe asthma, COPD (chronic obstructive pulmonary disease), ARDS (acute respiratory distress syndrome), pneumonia, fungal infections and haemophilia; chemical preparations for pharmaceutical use, namely, for the prevention and treatment of cancer and pseudomyxoma peritonei, for inhibiting the growth of bacteria or biofilms, for destroying biofilm infections, or for treating cystic fibrosis, sputum retention, chest infections, respiratory conditions, severe asthma, COPD, ARDS, pneumonia, fungal infections and haemophilia; compounds being pharmaceutical preparations for treating cancer; pharmaceutical compositions for the treatment and prevention of cancer and pseudomyxoma peritonei, for inhibiting the growth of bacteria or biofilms, for destroying biofilm infections, or for treating cystic fibrosis, sputum retention, chest infections, respiratory conditions, severe asthma, COPD, ARDS, pneumonia, fungal infections and haemophilia; pharmaceutical preparations for the treatment and prevention of cancer and pseudomyxoma peritonei, for inhibiting the growth of bacteria or biofilms, for destroying biofilm infections, or for treating cystic fibrosis, sputum retention, chest infections, respiratory conditions, severe asthma, COPD, ARDS, pneumonia, fungal infections and haemophilia; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of pseudomyxoma peritonei; pharmaceutical preparations for use in combination therapy for the treatment of cancer and pseudomyxoma peritonei; pharmaceutical preparations for treating glue ear, cystic fibrosis, sputum retention, chest infections, respiratory conditions, haemophilia, myocardial infarction, coronary artery disease, stroke, massive pulmonary embolism, acute limb ischemia, stent-related thrombosis or haemarthrosis; preparations of plants, namely, plant extracts for pharmaceutical use |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 27, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Mucpharm Pty Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Malvern VIC 3144 AU |
| Party Name | Mucpharm Pty Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Malvern VIC 3144 AU |
| Party Name | Mucpharm Pty Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Malvern VIC 3144 AU |
| Event Date | Event Description |
| Tuesday, January 3, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, January 3, 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Tuesday, January 3, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, January 3, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, January 18, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 2, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 2, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 13, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 28, 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, September 28, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, September 27, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 27, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, September 26, 2021 | ASSIGNED TO LIE |
| Monday, September 20, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, July 29, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, July 29, 2021 | LETTER OF SUSPENSION E-MAILED |
| Thursday, July 29, 2021 | SUSPENSION LETTER WRITTEN |
| Monday, July 12, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 12, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 12, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 3, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 3, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 3, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 3, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, October 27, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |